Phase II study of O6-benzylguanine [benzylguanine] and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas or progressive brain stem tumors.

Trial Profile

Phase II study of O6-benzylguanine [benzylguanine] and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas or progressive brain stem tumors.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Mar 2013

At a glance

  • Drugs Benzylguanine (Primary) ; Temozolomide (Primary)
  • Indications Brain cancer; Glioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Aug 2011 Planned end date changed from 1 Jul 2010 to 1 Oct 2011 as reported by ClinicalTrials.gov.
    • 10 Aug 2011 Planned end date changed from 1 Jul 2010 to 1 Oct 2011 as reported by ClinicalTrials.gov.
    • 08 Jun 2010 Planned end date changed from 1 May 2007 to 1 Jul 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top